- Report
- April 2025
- 93 Pages
Global
From €5339EUR$5,850USD£4,552GBP
- Report
- March 2025
- 200 Pages
Global
From €4098EUR$4,490USD£3,494GBP
- Report
- March 2025
- 200 Pages
Global
From €4098EUR$4,490USD£3,494GBP
- Report
- May 2024
- 137 Pages
Global
From €5931EUR$6,499USD£5,057GBP
- Report
- July 2024
- 150 Pages
Global
From €3422EUR$3,750USD£2,918GBP
- Report
- December 2024
- 30 Pages
Global
From €2510EUR$2,750USD£2,140GBP
- Report
- September 2024
- 343 Pages
Global
From €7255EUR$7,950USD£6,186GBP
- Report
- May 2021
- 50 Pages
China
From €2373EUR$2,600USD£2,023GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
€1369EUR$1,500USD£1,167GBP
- Report
- March 2023
- 147 Pages
Global
From €4517EUR$4,949USD£3,851GBP
- Report
- November 2023
- 135 Pages
Global
From €3650EUR$4,000USD£3,113GBP
- Report
- April 2023
- 117 Pages
Global
From €4335EUR$4,750USD£3,696GBP
- Report
- January 2023
- 85 Pages
Europe
From €1369EUR$1,500USD£1,167GBP
- Report
- January 2024
- 156 Pages
United States
€3468EUR$3,800USD£2,957GBP
- Report
- January 2024
- 114 Pages
United States
€3194EUR$3,500USD£2,724GBP
- Report
- July 2018
- 33 Pages
Global
From €9126EUR$10,000USD£7,782GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €456EUR$500USD£389GBP
- Report
- April 2025
- 50 Pages
Global
From €2418EUR$2,650USD£2,062GBP
- Report
- December 2022
- 210 Pages
Global
From €2357EUR$2,583USD£2,010GBP
€3368EUR$3,690USD£2,871GBP

Tiotropium is a long-acting anticholinergic drug used to treat chronic obstructive pulmonary disease (COPD). It is a bronchodilator, meaning it relaxes the muscles in the airways, allowing more air to flow in and out of the lungs. It is available in both an inhaler and a dry powder inhaler. Tiotropium is the only long-acting anticholinergic approved for the treatment of COPD. It is also used to treat asthma and other respiratory conditions.
Tiotropium is a popular drug in the respiratory drugs market, as it is effective in treating COPD and other respiratory conditions. It is also well-tolerated, with few side effects. It is available in both generic and brand-name forms, making it accessible to a wide range of patients.
Some companies in the Tiotropium market include Boehringer Ingelheim, GlaxoSmithKline, and Novartis. Show Less Read more